In this episode, the DIYBODY coaches break down the most talked-about topic in health and fitness right now: GLP-1 medications like Ozempic, Wegovy, Mounjaro, Zepbound — plus newer compounds like Retatrutide.

They explain what GLP-1s actually are, how they work in the body (brain, pancreas, gut), and why they were originally designed for type-2 diabetes before becoming mainstream for weight loss. The coaches unpack the real reasons they work: appetite suppression, quieter “food noise,” improved blood sugar control, and slower gastric emptying — but they also keep it real about the trade-offs.

You’ll hear an honest coaching perspective on who these drugs may genuinely help, why they’re not a shortcut, and what has to be in place to use them safely: strength training, protein, sleep, nutrient-dense meals, and lifestyle habits that still hold up once the medication stops. They also cover common risks and side effects to watch for, including muscle loss, nutrient deficiencies, digestion issues, rebound weight gain, emotional blunting, and the financial cost and accessibility challenges.

By the end, you’ll understand how GLP-1s work, who they’re for, and why they’re a tool — not a replacement for long-term health and sustainable fat loss.

Timestamps

00:00 – Intro: GLP-1s are everywhere + what this episode will cover
00:32 – Disclaimer: education only, talk to your doctor
00:52 – What GLP-1 is and what it does (naturally produced hormone)
01:33 – How GLP-1 drugs “mimic” the hormone and bind to receptors
01:54 – The 3 main target areas: brain, pancreas, gut
02:20 – Slower gastric emptying: why you feel full longer
02:45 – GLP-1 is the start; newer drugs add more “pathways”
03:13 – Blood sugar stability: why it matters for health + appetite
03:58 – Coaching perspective shift: more open-minded now with more research
04:21 – Why these were originally for type-2 diabetes
04:35 – Weight loss as a “side effect” → boom in popularity
04:46 – What “food noise” means and why it’s become a big term
05:24 – Semaglutide vs tirzepatide vs retatrutide (what makes them different)
05:43 – Retatrutide explained: “triple action” overview
06:09 – GIP pathway: insulin use + fat storage regulation
06:38 – Glucagon pathway: metabolism/energy output side of the discussion
07:23 – Retatrutide isn’t FDA approved yet (still in trials)
08:02 – Injectable vs oral: why injectables tend to be more effective
08:41 – Let’s talk cost: what people are paying per month
09:27 – Canada pricing example + insurance barriers
10:05 – Accessibility issues + shortages affecting people who medically need it
11:17 – Does it work? Yes — and typical weight loss ranges discussed
12:30 – Coaching lens: it only works long-term with lifestyle changes
13:38 – Hunger hormones + how GLP-1s change appetite signaling
14:27 – Food noise reduction can create self-awareness around emotional eating
15:49 – “Why not everyone then?” → cost, choice, and candidacy
16:15 – Who it’s best suited for: diabetes, insulin resistance, obesity, repeated failure despite structure
17:26 – Not for the “last 10–20 lbs” for most people
18:17 – Dopamine/reward blunting: possible emotional side effects
19:38 – Tool vs shortcut: lifestyle is still the driver
21:28 – Risk vs reward: obesity vs vanity use
23:04 – Older population risks: muscle loss, frailty, osteoporosis concerns
25:02 – Common side effects: muscle loss, nutrient deficiency, GI issues
25:36 – Less common/serious risks mentioned: pancreatitis, gallstones (still being explored)
26:08 – Weight loss vs fat loss: why losing “weight” can backfire
27:01 – Missing piece: protein + training (to keep a toned body)
27:51 – Relationship with food: growth vs just relying on the drug
29:16 – Coaching challenge: hunger cues get muted, harder to use biofeedback
29:55 – Real client ex